Search results for "Side effects"
New COVID-19 vaccine authorized; reviews analyze myocarditis, drug treatments
The FDA gave the Novavax COVID-19 vaccine emergency use authorization for adults. One recent review found lower myocarditis risk with the Pfizer-BioNTech vaccine than the Moderna vaccine, and another looked at the strength of evidence supporting COVID-19 drug treatments.
https://immattersacp.org/weekly/archives/2022/07/19/4.htm
19 Jul 2022
RSV vaccines new tool for physicians
The CDC's Advisory Committee on Immunization Practices recommended in June that adults ages 60 years and older may receive a single dose of an RSV vaccine, using shared clinical decision making.
https://immattersacp.org/archives/2023/10/rsv-vaccines-new-tool-for-physicians.htm
1 Oct 2023
Warning on an antipsychotic; generic rosuvastatin approval
This update covers new warnings on the entire class of opioids and approval of the first leadless pacemaker approved to treat heart rhythm disorders.
https://immattersacp.org/archives/2016/06/fda.htm
1 Jun 2016
Updated warning issued on risks of fluoroquinolones
Fluoroquinolone use for sinusitis, bronchitis, and uncomplicated urinary tract infections should be reserved for patients who do not have alternative treatment options, according to an FDA safety communication.
https://immattersacp.org/weekly/archives/2016/05/24/5.htm
24 May 2016
MKSAP Quiz: Routine visit for hypertension
A 57-year-old man is evaluated during a routine visit. History is significant for hypertension. Following a physical exam and lab studies, what is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2019/05/14/3.htm
14 May 2019
Latest COVID-19 research looks at plasma, prophylaxis, palliative care, periop risks
The benefit of convalescent plasma is uncertain, and hydroxychloroquine did not appear to work for prophylaxis, according to new studies. Experts offered advice on using palliative care, avoiding surgery, changing residency applications, and understanding antibody testing.
https://immattersacp.org/weekly/archives/2020/06/09/1.htm
9 Jun 2020
The never-ending push-pull of statins
Statins have proven their potential to reduce end-point outcomes, such as death from cardiovascular disease. But the drug class also has some downsides, and the pros and the cons become a close call.
https://immattersacp.org/archives/2017/04/statins.htm
1 Apr 2017
Rethinking SIBO in the microbiome era
Small intestinal bacterial overgrowth is thought of as very rare, but in an era of booming microbiome research, gastroenterologists and other physicians are starting to become more aware of SIBO in the general population and provide effective treatment
https://immattersacp.org/archives/2019/05/rethinking-sibo-in-the-microbiome-era.htm
1 May 2019
Approval for cancer drug; proposed ban for gloves
This update covers approval of Crizotinib (Xalkori) to treat people with metastatic non-small-cell lung cancer whose tumors have an ROS-1 gene alteration.
https://immattersacp.org/archives/2016/05/fda.htm
1 May 2016
Handling hoarseness, hearing problems in primary care
Internists can help patients cope with common ENT conditions like hoarseness, tinnitus, and hearing loss.
https://immattersacp.org/archives/2021/06/handling-hoarseness-hearing-problems-in-primary-care.htm
1 Jun 2021